Slack pursued an unusual direct listing, meaning it did not have banks underwrite the offering.CNBC Disruptor 50read more
President Trump says Iran may not have intentionally downed an unmanned U.S. surveillance drone.Politicsread more
Slack's CEO said that the company didn't want to go public via an IPO so that it could be as transparent and accessible as possible.Deals and IPOsread more
Oil jumped as much as 6% on Thursday after Iran shot down a U.S. military drone, prompting President Trump to blast Tehran on Twitter.Energy Commoditiesread more
If Facebook cut corners in something as basic as the branding of its nascent crypto efforts, this dispute could give ammunition to its many critics.Financeread more
CNBC analysis using Kensho found that Disney, Verizon and Home Depot were some of the best performing Dow stocks in declining-rate environments.Investingread more
For doubters thinking the rally is just a last gasp of the decade-long bull market, chart analysts are here to prove them wrong.Marketsread more
Notorious "pharma bro" Martin Shkreli has reached a settlement with his former biopharmaceutical company Retrophin just weeks ago after he sued two company directors and its...Biotech and Pharmaceuticalsread more
"The slowdown in the global economy is reaching this shore," veteran trader Art Cashin says.Economyread more
Slack's public market debut on Thursday will generate billions for venture firm Accel and healthy returns for Andreessen Horowitz and Social CapitalTechnologyread more
JetBlue is ordering the longest-range Airbus jets to expand service to more European cities.Airlinesread more
The opioid epidemic in the United States has "peaked," says Dr. Toby Cosgrove, one of the nation's leading voices on health-care reform.
"We're starting to see the understanding of the problem," Cosgrove said Monday on CNBC's "Squawk Box. " "[We] are getting to the point where people are certainty prescribing fewer drugs and people are recognizing how serious this is."
But Cosgrove, former CEO of the renowned Cleveland Clinic, also said opioids remain a major health risk for Americans, especially from drugs laced with synthetic opioids such as the pain killer fentanyl or ones with similar effects like carfentanil.
"Carfentanil is 10,000 times as potent as morphine. These drugs are getting laced," said Cosgrove, who is also a cardiac surgeon. "We just had an outbreak of deaths in Ohio from drugs being laced with very potent carfentanil and fentanyl."
Opioids — including heroin, a poppy seed derivative, and lab-made fentanyl — were involved in more than 42,000 overdose deaths in 2016, according to the Centers for Disease Control and Prevention.
The opioid epidemic affects American children as well.
The number of pediatric opioid hospitalizations requiring intensive care nearly doubled to 1,504 patients between 2012 and 2015, from 797 patients between 2004 and 2007, according to a study published by Pediatrics.
President Donald Trump has attacked drugmakers for their role in fueling the opioid epidemic and released a plan to reduce the number of opioid prescriptions in the U.S.
Google announced in July that Cosgrove would join the Google Cloud Healthcare and Life Sciences team as an executive advisor. He will assist in the Alphabet unit's goal of lowering costs health costs and improving patient experiences.
Cosgrove led the Cleveland Clinic for nearly 13 years before stepping down in May 2017.